Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
about
Treatment and prophylaxis of invasive candidiasisPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsAcute and chronic effects of flucytosine on amphotericin B nephrotoxicity in ratsActivity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycosesComparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitisImprovement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomesTreatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combinationFungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitroIn vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with IntralipidCryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.History of medical mycology in the united states.Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography.Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study.The therapeutic monitoring of antimicrobial agents.Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion.The past, present and future of antimycotic combination therapy.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Antifungal pharmacodynamics: review of the literature and clinical applications.Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity.Management of cryptococcal meningitis in HIV-infected patients: Experience from western India.Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitisAntifungal pharmacokinetics and pharmacodynamicsInfluence of diet on experimental toxicity of amphotericin B deoxycholate.Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats.Pharmacokinetics of antifungal agents in children.Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitisAntifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.Systemic Candida infections.Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics.Antifungal therapeutic drug monitoring: established and emerging indications.Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.Combination antifungal therapy for invasive fungal infections in children and adults.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Drug-induced acid-base disorders.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.Therapeutic drug monitoring of anti-infective agents in critically ill patients.
P2860
Q27001567-18086CBD-0C30-41EF-BCBF-320D83F73B2BQ27025299-3325C44A-12EA-497D-A856-58C817F2EB57Q28318066-89C6C41E-23B0-4E68-AF98-9D8610D011BFQ28318068-C54DC637-AA6D-4313-BD97-FD7AF8ED9488Q28319936-6DCB1475-BAD5-405B-9775-0809E18FE567Q28328605-2C96D11A-1C37-456F-B5B5-0BBA100075E9Q28333963-6580A02E-4E17-47A0-84E9-D7A4CB8A19CEQ28369533-0A247C2E-E2B6-49ED-A896-E357BE0127B0Q28369708-29CDD3D7-0B79-4080-9B43-92BE3D853A42Q30424017-D33F3D3A-41FF-4AFA-9208-A37FC038A0B3Q30452877-6ADEFA6A-EF7F-4F11-B846-7EC7FA6441CFQ30984298-3885316A-6B2E-48CD-8DE5-0B5B9F9F2A6AQ33272469-FC9C0FC3-82FC-4CDB-A456-D98501B1AF73Q33341541-D1823E5C-CA0F-4748-B89A-4F015A93A4BEQ33540451-84072EDB-2C3C-4AC8-98DB-AD0B9C324F1DQ33691165-D60DF1D3-45C2-4306-9520-008B535BB07BQ33760507-540DFE2A-C9C4-414F-85AC-179A5157A6AEQ34020746-2A36DE4F-6D1D-48E0-A7CC-FB77FE7FB855Q34083129-D3C41E1A-D41E-4DFC-81A2-BFB8A15B4BFCQ34338060-CF6339B0-81DA-4CB9-8ACD-AC4CAA38B14FQ35117289-16B82B48-2E87-482E-B38A-7D62C5A39B2EQ35127069-5CAB7BAF-E244-4D67-BA6E-5A4DD0F42829Q35663841-4D63E6E0-DAF8-40C6-98C7-317955E4F19DQ35820200-DFC9669D-E958-46FC-8165-C4A2DD215089Q35824054-53A1F412-BA95-44ED-81E4-CF6F0A21C435Q35885347-1B05F16D-7E3E-4B2B-BA2C-6387B6C696A6Q36163345-B7D7B8D9-3474-4665-B742-22741584586FQ36489747-F00A6931-AF79-4645-AF5C-E1EC68BD94E0Q36753389-549263BC-2FB2-4C1A-9DCD-6110C0304E0DQ36948094-E23E46F4-F5AF-4517-8771-3C01F0E5CBD9Q36987671-521AF73C-EAC6-4CE5-A7AF-78BFA549EDB2Q37281096-3C3C1E19-6EFE-4052-BDE4-C7A1B53A9F83Q37310029-AF322EDB-C492-4950-A7D5-93FC34633B7CQ37688257-1133D292-B57A-4ED1-80C7-35FF5D109E78Q38102782-B61786DC-A4C2-421A-9E77-0BD98827BF30Q38193337-0D72BEC0-5BC3-45E1-B67D-809DF69D8BC4Q38265082-BF3242D5-A87B-4C60-8105-8A4E1F62071DQ38284468-EA000814-A5A9-4986-A04A-FAB0091DBED3Q38738090-DC682229-7144-4623-881F-21C4660102D1Q38790740-0B0D984F-D9BC-4080-AA3D-6039B178082A
P2860
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@ast
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@en
type
label
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@ast
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@en
prefLabel
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@ast
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@en
P2093
P1476
Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
@en
P2093
Dismukes WE
Espinel-Ingroff A
P304
P356
10.1016/0002-9343(87)90691-7
P407
P577
1987-08-01T00:00:00Z